Suppr超能文献

单纯腹腔镜与开腹左外侧肝段切除术治疗肝细胞癌:单中心经验

Pure Laparoscopic Versus Open Left Lateral Sectionectomy for Hepatocellular Carcinoma: A Single-Center Experience.

作者信息

Cheung Tan To, Poon Ronnie T P, Dai Wing Chiu, Chok Kenneth S H, Chan See Ching, Lo Chung Mau

机构信息

Department of Surgery, Queen Mary Hospital, The University of Hong Kong, 102 Pokfulam Road, Hong Kong, China.

出版信息

World J Surg. 2016 Jan;40(1):198-205. doi: 10.1007/s00268-015-3237-8.

Abstract

INTRODUCTION

Laparoscopic left lateral sectionectomy has been proven to be a safe and effective treatment for liver lesions. However, most of the literatures only reported this treatment method on benign lesion or colorectal metastases. The data on long-term outcome of laparoscopic left lateral section resection in patients with HCC and cirrhosis are still limited. The aim of this study is to analyze the survival outcome of laparoscopic left lateral sectionectomy when compared to open approach in patients with HCCs.

METHOD

Between January 2004 and September 2014, 967 patients had primary HCC with hepatectomy performed. Twenty-four patients had undergone pure laparoscopic left lateral sectionectomy for hepatocellular carcinoma (HCC). Twenty-nine patients with case-matched tumor characteristics and liver functions but received open left lateral sectionectomy for HCC were included for comparison.

RESULTS

Comparing laparoscopic group to open resection group, the median operation time was 190.5 versus 195 min (P = 0.734); the median blood loss was 100 versus 300 ml (P < 0.001). Hospital stay was 5 days in laparoscopic group versus 6 days in the open group (P = 0.057). There was no difference between the two groups in terms of complications (P = 0.495). The median survival in laparoscopic group was >115 months versus >125 months in the open group (P = 0.853).

CONCLUSION

Laparoscopic left lateral sectionectomy for HCC is a safe and simple procedure associated with less blood loss. The survival outcome is comparable with conventional open approach. It is becoming a more favorable treatment option even for patients with HCC and cirrhosis.

摘要

引言

腹腔镜左外叶切除术已被证明是治疗肝脏病变的一种安全有效的方法。然而,大多数文献仅报道了该治疗方法用于良性病变或结直肠癌转移。关于腹腔镜左外叶切除术治疗肝癌合并肝硬化患者的长期预后数据仍然有限。本研究的目的是分析与开腹手术相比,腹腔镜左外叶切除术治疗肝癌患者的生存结局。

方法

2004年1月至2014年9月期间,967例原发性肝癌患者接受了肝切除术。24例患者接受了单纯腹腔镜左外叶切除术治疗肝细胞癌(HCC)。纳入29例肿瘤特征和肝功能匹配但接受开腹左外叶切除术治疗HCC的患者进行比较。

结果

腹腔镜组与开腹切除组相比,中位手术时间分别为190.5分钟和195分钟(P = 0.734);中位失血量分别为100毫升和300毫升(P < 0.001)。腹腔镜组住院时间为5天,开腹组为6天(P = 0.057)。两组并发症发生率无差异(P = 0.495)。腹腔镜组中位生存期>115个月,开腹组>125个月(P = 0.853)。

结论

腹腔镜左外叶切除术治疗肝癌是一种安全、简单的手术,失血较少。生存结局与传统开腹手术相当。即使对于肝癌合并肝硬化患者,它也正成为一种更有利的治疗选择。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验